Girdhari Lal Bawri (#2259)
- $ 2 B
- Pharmaceuticals
- India
- M
- 78 Years
Rest in Peace Ask Jeeves, every search comes to an end
County commissioners call on lawmakers to up funding for 911 dispatch systems
Spirit Airlines Is Going Out Of Business; Effective IMMEDIATELY
Pokémon Scalpers Selling Limited-Edition Pop-Tarts For Ridiculous Prices
Bennett says Netanyahu gov't 'boycotting' West Bank settlements amid Carrefour subsidy deal
Golf gear on sale now: Up to 65% off adidas, 45% off Puma, 15% off Mizuno, more
Families across the US can't find childcare — this map shows where it's worst
Median sales surge 61% in a Queens neighborhood that’s now the fifth priciest in NYC
Greg Brockman says his stake in OpenAI is worth nearly $30 billion
TeraWulf Announces Participation in Upcoming Investor and Industry Conferences
About Me
Girdharilal Bawri is the chairman of Macleods Pharmaceuticals, which is among India's top 10 pharma firms. Bawri, whose family owned a pharmacy in Jaipur, set up Macleods Pharmaceuticals in 1986 with his two siblings to make anti-TB medicines. Macleods produces generics for a range of diseases including asthma, osteoporosis and diabetes. His younger brothers, Rajendra Agrawal and Banwarilal Bawri, are managing director and joint managing director respectively.
Achievements
Career Highlights
A snapshot of the defining milestones, leadership decisions, and breakthroughs that shaped Girdhari Lal Bawri’s rise and global influence.
Wealth Growth
Net Worth Growth Over Time
Tracking Girdhari Lal Bawri’s net worth journey over the years, highlighting key growth phases and financial milestones.
Current Net Worth: $1.8B
(May 4, 2026)
© Iconic Billionaires